BTIG analyst Ryan Zimmerman downgrades Globus Medical (NYSE:GMED) from Buy to Neutral.
Oppenheimer Upgrades Wix.com to Outperform, Announces $110 Price Target
Oppenheimer analyst Ken Wong upgrades Wix.com (NASDAQ:WIX) from Perform to Outperform and announces $110 price target.